New GLP-1 trends, FDA approvals and emerging safety concerns.
April 15, 2026

1. Genes may predict GLP-1 weight loss: Study Full story

2. FDA approves 1st generics of Farxiga for Type 2 diabetes Full story

3. Advocate Health, Mayo Clinic and 515+ speakers at Becker's Health IT event — apply to be a reviewer here.

 

4. FDA adds seizure warning to CSL flu vaccine label Full story

5. 4 ways GLP-1s are changing care patterns, patient behavior Full story

6. Pharmacy leaders are rethinking procurement. Their approach to reducing risk and protecting margins here.

 

7. Florida restores HIV drug access with $30.9M emergency funding Full story

8. Global stockout halts access to hemophilia B gene therapy Full story

Becker's Learning Opportunities

9. Why are so many behavioral health referrals not converting to care? Get answers here.

10. Learn how clinicians can identify inherited cardiovascular risk earlier here.

11. Henry Ford Health sees diagnostics as a strategic asset. Learn why here.

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication